These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 18979610)

  • 41. Acute pancreatitis caused by tigecycline: A case report and literature review.
    Wang PF; Zou H; Zhu JH; Shi FE
    Medicine (Baltimore); 2021 Dec; 100(51):e28245. PubMed ID: 34941095
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacokinetics and safety of a single intravenous dose of the antibiotic tigecycline in patients with cirrhosis.
    Korth-Bradley JM; Baird-Bellaire SJ; Patat AA; Troy SM; Böhmer GM; Gleiter CH; Buecheler R; Morgan MY
    J Clin Pharmacol; 2011 Jan; 51(1):93-101. PubMed ID: 20308689
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Tigecycline, the first of a new class of antibiotics: the glycylcyclines].
    Bosó-Ribelles V; Roma-Sánchez E; Salavert-Lletí M; Hernández-Martí V; Poveda-Andrés JL
    Rev Esp Quimioter; 2007 Mar; 20(1):19-35. PubMed ID: 17530033
    [No Abstract]   [Full Text] [Related]  

  • 44. Tigecycline: a novel broad-spectrum antimicrobial.
    Slover CM; Rodvold KA; Danziger LH
    Ann Pharmacother; 2007 Jun; 41(6):965-72. PubMed ID: 17519296
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tigecycline (tygacil).
    Med Lett Drugs Ther; 2005 Sep; 47(1217):73-4. PubMed ID: 16151368
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tigecycline: first of a new class of antimicrobial agents.
    Rose WE; Rybak MJ
    Pharmacotherapy; 2006 Aug; 26(8):1099-110. PubMed ID: 16863487
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Activity of tigecycline tested against a global collection of Enterobacteriaceae, including tetracycline-resistant isolates.
    Fritsche TR; Strabala PA; Sader HS; Dowzicky MJ; Jones RN
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):209-13. PubMed ID: 16105566
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy of tigecycline pleurodesis: a comparative experimental study.
    Daddi N; Vannucci J; Maggio C; Giontella A; Bravi I; Marziani F; Capozzi R; Ragusa M; Bufalari A; Puma F
    J Surg Res; 2011 Aug; 169(2):e109-18. PubMed ID: 20934718
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A review of tigecycline--the first glycylcycline.
    Peterson LR
    Int J Antimicrob Agents; 2008 Dec; 32 Suppl 4():S215-22. PubMed ID: 19134522
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Resistance to a beta-lactam antibiotic appearing during therapy for enterobacter cloacae sepsis in a child.
    Muñoz M; Márquez C; Taguas-Casaño M; Soult JA; López-Castilla JD; Alvarez-Silván AM
    Med Pediatr Oncol; 2003 Jan; 40(1):62-3. PubMed ID: 12426691
    [No Abstract]   [Full Text] [Related]  

  • 51. Tigecycline: a single antibiotic for polymicrobial infections.
    Pankey GA; Steele RW
    Pediatr Infect Dis J; 2007 Jan; 26(1):77-8. PubMed ID: 17195711
    [No Abstract]   [Full Text] [Related]  

  • 52. Tigecycline: benefits and risks.
    Cai Y; Wang R
    Lancet Infect Dis; 2011 Nov; 11(11):804-5. PubMed ID: 21784707
    [No Abstract]   [Full Text] [Related]  

  • 53. Bullous haemorrhagic cellulitis caused by Enterobacter cloacae.
    Dyachenko P; Ziv M; Kamil S; Dodiuk-Gad R; Chazan B; Rozenman D
    J Eur Acad Dermatol Venereol; 2005 Nov; 19(6):763-4. PubMed ID: 16268890
    [No Abstract]   [Full Text] [Related]  

  • 54. Antibiotic coresistance in extended-spectrum-beta-lactamase-producing Enterobacteriaceae and in vitro activity of tigecycline.
    Morosini MI; García-Castillo M; Coque TM; Valverde A; Novais A; Loza E; Baquero F; Cantón R
    Antimicrob Agents Chemother; 2006 Aug; 50(8):2695-9. PubMed ID: 16870760
    [TBL] [Abstract][Full Text] [Related]  

  • 55. One-year experience with tigecycline in treating serious infections in severely burned patients.
    Lipový B; Rihová H; Hanslianová M; Brychta P
    Acta Chir Plast; 2009; 51(3-4):69-71. PubMed ID: 20514890
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tigecycline for treatment of pneumonia and empyema caused by carbapenemase-producing Klebsiella pneumoniae.
    Daly MW; Riddle DJ; Ledeboer NA; Dunne WM; Ritchie DJ
    Pharmacotherapy; 2007 Jul; 27(7):1052-7. PubMed ID: 17594211
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evidence for low risk of Clostridium difficile infection associated with tigecycline.
    Wilcox MH
    Clin Microbiol Infect; 2007 Oct; 13(10):949-52. PubMed ID: 17697004
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Bacterial resistance and a new antibiotic: tigecycline].
    Gobernado M
    Rev Esp Quimioter; 2006 Sep; 19(3):209-19. PubMed ID: 17099789
    [No Abstract]   [Full Text] [Related]  

  • 59. Tigecycline: a review of properties, applications, and analytical methods.
    da Silva LM; Nunes Salgado HR
    Ther Drug Monit; 2010 Jun; 32(3):282-8. PubMed ID: 20431506
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tigecycline: place in therapy and important considerations.
    Garrelts JC; Schroeder T
    Am J Health Syst Pharm; 2006 Jul; 63(13):1233. PubMed ID: 16790574
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.